Literature DB >> 6539218

Epidemiologic data on excess mortality and life expectancy in insulin-dependent diabetes mellitus--critical review.

G Panzram.   

Abstract

Generalizations of prognosis with regard to insulin-dependent diabetes (IDDM) in epidemiological statistics are impaired not only by great intraindividual variations, but also due to methodical difficulties. Due to recent prognostic studies IDDM, particular in young age, must be considered as a rather serious disease with a 5 to 10 fold higher excess mortality in comparison with the general population. There are only few exact data about the extent of life shortening. Age of onset represents the most significant factor in life shortening. The younger the patient is at the age of onset the shorter he lives. From about 70 years onward diabetes has little or no effect on longevity. Whether the prognosis of IDDM has improved within the last decades remains uncertain. Long-term studies clearly indicate that IDDM is compatible also with a long life in a good health. Why many diabetics develop life shortening complications and why some patients do not cannot be answered with conclusive evidence.

Entities:  

Mesh:

Year:  1984        PMID: 6539218     DOI: 10.1055/s-0029-1210316

Source DB:  PubMed          Journal:  Exp Clin Endocrinol        ISSN: 0232-7384


  7 in total

1.  Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway.

Authors:  T Skrivarhaug; H-J Bangstad; L C Stene; L Sandvik; K F Hanssen; G Joner
Journal:  Diabetologia       Date:  2005-12-20       Impact factor: 10.122

2.  The mortality of children with type 1 (insulin-dependent) diabetes mellitus in Norway, 1973-1988.

Authors:  G Joner; S Patrick
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

Review 3.  Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  G Panzram
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

Review 4.  A new perspective on mechanisms governing skeletal complications in type 1 diabetes.

Authors:  Zeynep Seref-Ferlengez; Sylvia O Suadicani; Mia M Thi
Journal:  Ann N Y Acad Sci       Date:  2016-08-29       Impact factor: 5.691

5.  Markedly increased renal disease mortality and incidence of renal replacement therapy among IDDM patients in Japan in contrast to Allegheny County, Pennsylvania, USA. Diabetes Epidemiology Research International (DERI) U.S.-Japan Mortality Study Group.

Authors:  M Matsushima; N Tajima; R E LaPorte; T J Orchard; E S Tull; I F Gower; T Kitagawa
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

6.  Socioeconomic and behavioural risk factors for mortality of individuals with IDDM in Japan: population-based case-control study. Diabetes Epidemiology Research International (DERI) US-Japan Mortality Study Group.

Authors:  M Matsushima; K Shimizu; M Maruyama; R Nishimura; R E LaPorte; N Tajima
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

7.  Mortality in Israeli Jewish patients with type 1 (insulin-dependent) diabetes mellitus diagnosed prior to 18 years of age: a population based study.

Authors:  M Modan; M Karp; B Bauman; O Gordon; Y L Danon; Z Laron
Journal:  Diabetologia       Date:  1991-07       Impact factor: 10.122

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.